ValueAct Capital Shows 7.1% Stake in Bioverativ (BIVV)
Tweet Send to a Friend
In a 13D filing on Bioverativ (NASDAQ: BIVV), hedge fund ValueAct Capital disclosed a 7.1%, or 7,700,000 share, stake in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
